Balloon bifurcated lumen treatment

Information

  • Patent Grant
  • 8936567
  • Patent Number
    8,936,567
  • Date Filed
    Friday, June 5, 2009
    15 years ago
  • Date Issued
    Tuesday, January 20, 2015
    9 years ago
Abstract
Balloon systems for treating bifurcated lumens include desirable burst and folding characteristics. In some cases, the balloon systems can be formed by varying the wall thickness of a balloon parison.
Description
TECHNICAL FIELD

This disclosure relates to the treatment of bifurcated lumens with a balloon.


BACKGROUND

The body includes various passageways including blood vessels such as arteries, and other body lumens. These passageways sometimes become occluded or weakened. For example, they can be occluded by a tumor, restricted by plaque, or weakened by an aneurysm. When this occurs, the passageway can be reopened or reinforced, or even replaced, with a medical endoprosthesis. An endoprosthesis is an artificial implant that is typically placed in a passageway or lumen in the body. Many endoprostheses are tubular members, examples of which include stents, stent-grafts, and covered stents.


Many endoprostheses can be delivered inside the body by a catheter. Typically the catheter supports a reduced-size or compacted form of the endoprosthesis as it is transported to a desired site in the body, for example, the site of weakening or occlusion in a body lumen. Upon reaching the desired site, the endoprosthesis is installed so that it can contact the walls of the lumen.


One method of installation involves expanding the endoprosthesis. The expansion mechanism used to install the endoprosthesis may include forcing it to expand radially. For example, the expansion can be achieved with a catheter that carries a balloon in conjunction with a balloon-expandable endoprosthesis reduced in size relative to its final form in the body. The balloon is inflated to deform and/or expand the endoprosthesis in order to fix it at a predetermined position in contact with the lumen wall. The balloon can then be deflated, and the catheter withdrawn.


Body lumens often include bifurcated regions with branching pathways. Treatments, such as angioplasty and stent delivery, are sometimes required at locations proximate the branching physiology.


SUMMARY

The following summary is provided to facilitate an understanding of some of the innovative features unique to the present disclosure and is not intended to be a full description. A full appreciation of the disclosure can be gained by taking the entire specification, claims, drawings, and abstract as a whole.


In one embodiment, a medical device for treating a bifurcated lumen is described. The medical device may include a catheter shaft having a proximal region and a distal region, a first balloon disposed about a distal region of the catheter shaft along an axis of the catheter shaft, and a second balloon coupled to the distal region of the catheter shaft and disposed offset from the axis. The second balloon may have an expandable region configured to expand in a direction at an angle from the axis and the second balloon may have a base region opposite the expandable region, wherein the wall thickness of the base region is greater than the wall thickness of the expandable region.


In another embodiment, a medical device for treating a bifurcated lumen is described. The medical device may include a catheter shaft having a proximal region and a distal region, a first balloon disposed about a distal region of the catheter shaft along an axis of the catheter shaft, and a second balloon coupled to the distal region of the catheter shaft and disposed offset from the axis. The second balloon may have an expandable region configured to expand in a direction at an angle from the axis and a base region opposite the expandable region, wherein the second balloon includes a predefined burst region.


In another embodiment, a medical device for treating a bifurcated lumen is described. The medical device may include a catheter shaft having a proximal region and a distal region, a first balloon disposed about a distal region of the catheter shaft along an axis of the catheter shaft, and a second balloon coupled to the distal region of the catheter shaft and disposed offset from the axis. The second balloon may have an expandable region configured to expand in a direction at an angle from the axis and a base region opposite the expandable region, wherein the balloon has a predefined fold region in the base region and/or expandable region.


In other embodiment, a medical device for treating a bifurcated lumen is described. The medical device may include a catheter shaft having a proximal region and a distal region, a first balloon disposed about a distal region of the catheter shaft along an axis of the catheter shaft, and a second balloon coupled to the distal region of the catheter shaft and disposed offset from the axis. The second balloon may have an expandable region configured to expand at an angle from the axis a base region opposite the expandable region, wherein the first balloon and second balloon are concentrically disposed about the catheter shaft.


In another embodiment, a medical device for treating a bifurcated lumen is described. The medical device may include a catheter shaft having a proximal region and a distal region and a balloon coupled to the distal region of the catheter shaft. The balloon may include an electroactive polymer, wherein an exposure to an electrical current may cause the electroactive polymer to expand such that the balloon folds into lobes.


In another embodiment, a method of forming a balloon for treating a bifurcated lumen is described. The method may include providing a tubular parison defining an axis and having a variable wall thickness region, utilizing the variable wall thickness region of the parison to form a balloon inflatable off the axis, and expanding the parison to form the balloon such that a first region of the parison having a greater thickness is expanded to a greater extent than a second region of the parison having a lesser thickness.





BRIEF DESCRIPTION OF DRAWINGS

The invention may be more completely understood in consideration of the following detailed description of various illustrative embodiments of the disclosure in connection with the accompanying drawings, in which:



FIGS. 1A-1D are cross-sectional views illustrating delivery and deployment of a stent in a bifurcated lumen.



FIG. 2A is a cross-sectional view through a portion of a balloon catheter.



FIG. 2B is a perspective view illustrating a portion of a balloon catheter.



FIGS. 3A and 3B are transverse cross-sectional views through a balloon parison and a balloon wall, respectively.



FIGS. 4A-7 are schematics illustrating manufacture of a parison and balloon in FIGS. 3A and 3B.



FIGS. 4A and 4B are perspective views, and FIG. 4C is a cross-sectional view illustrating a snapshot of a process of drawing a balloon precursor tube through a die.



FIG. 5A is a perspective view, and FIG. 5B is a transverse cross-sectional view (section AA in FIG. 5A) of a balloon parison.



FIG. 6A is a schematic illustrating processing the balloon parison with laser radiation. FIG. 6B is a perspective view, and FIG. 6C is a transverse cross sectional view, (section BB in FIG. 6C) of the parison after processing.



FIG. 7 is a perspective view illustrating processing of the balloon parison in a blowing mold.



FIGS. 8-11 are end-on cross-sectional views through balloon parisons.



FIG. 12 is a schematic illustrating a cross-section of a balloon resulting from the balloon parison of FIG. 8.



FIG. 13A is a perspective view of a balloon having preferential burst mode. FIG. 13B is a bottom view of the balloon in FIG. 13A. FIG. 13C is a cross-sectional view of the balloon in FIG. 13A illustrating balloon burst.



FIG. 14A is a transverse cross section of a parison for forming the balloon in FIG. 13A. FIG. 14B is a transverse cross section of the balloon formed from the parison in FIG. 14A. FIG. 14C is a transverse cross-sectional view illustrating balloon burst.



FIG. 15 is a bottom view of a balloon having a preferential folding region.



FIG. 16A is a perspective view and FIG. 16B is a transverse cross-sectional view of the balloon in FIG. 15.



FIGS. 17A and 17B are perspective and cross-sectional views of the balloon in FIGS. 16A and 16B during an initial stage of deflation.



FIGS. 18A and 18B are perspective and cross-sectional views respectively of the balloon in FIGS. 17A and 17B in a further deflated condition.



FIGS. 19A and 19B are bottom and cross-sectional views respectively of a balloon.



FIGS. 20A and 20B are bottom and cross-sectional views respectively of a balloon.



FIGS. 21A and 21B are top and perspective views respectively of a balloon.



FIGS. 22-24 are top views of a balloon.



FIGS. 25-26 are perspective views of bifurcation side branch balloons that have been ablated.



FIG. 27 shows an axial cross section of an ablated balloon.



FIGS. 28-29 show bottom views of an offset side branch balloon.





DETAILED DESCRIPTION

The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.


Referring to FIGS. 1A-1D, a body lumen 10, such as a blood vessel, that has a bifurcated region 11 is treated with a catheter 12 carrying a stent 14 over an inflatable balloon system 15. At the bifurcated region 11, the body lumen 10 forms a first branch 16 and a second branch 18. Referring particularly to FIG. 1A, the catheter 12 may be delivered through a tortuous pathway over a guidewire 13 to the treatment site about the bifurcated region 11. Referring as well to FIGS. 1B and 1C, the balloon system 15 is expanded to expand the stent 14 into contact with the wall of the body lumen 10. Referring to FIG. 1D, the balloon system 15 is then deflated and the catheter 12 withdrawn, leaving the stent 14 in place.


The stent 14 is arranged such that it can be placed in the bifurcated region 11. In this embodiment, the stent 14 includes distal 20 and proximal 22 openings as well as a side opening 24 such that the stent 14 will not obstruct the second branch 18 when it is positioned to span the bifurcated region in the first branch 16. In addition, the stent 14 includes a main axis region 26 which is along the axis A (shown in FIG. 1D) of the stent 14 and is expanded into contact with the first branch 16 and an off-axis region 28 that is expanded into contact with the second branch 18. The balloon system 15 likewise includes a main axis region 30, for expanding the main axis 26 of the stent, and an off-axis region 32 that expands the off-axis region 28 of the stent.


Referring to FIGS. 2A and 2B, a cross section and perspective view, respectively of the distal end of a balloon catheter 33 suitable for placement in a lumen 16, as in, for example, FIGS. 1A and 1B, the catheter 33 includes an inner shaft 34 defining a guidewire lumen 36, an outer shaft 38, and a dual balloon system. The concentric inner and outer shafts define an annular lumen 37 through which inflation fluid can be directed to the balloon system. The dual balloon system has a first, main balloon 42, including a region 54 that inflates into a generally cylindrical profile aligned along the axis B of the catheter to expand the stent in the first branch 16 of the lumen. The main balloon 42 also includes proximal and distal sleeves or waists 56, 58, that are attached to the catheter. The system also includes a second, off-axis balloon 44 that expands off the axis of the catheter into the second branch 18 of the lumen. The off-axis balloon 44 extends along and around a portion of the main balloon and includes a base portion 41, an apex or dome 43, and proximal and distal sleeves 51, 53. The proximal sleeves of both balloons are attached at a region 47 of outer shaft 38 and the distal sleeves of both balloons are attached to a distal region 49 of the inner shaft of the catheter. The proximal sleeve 51 or leg of the off-axis balloon 44 provides a pathway 50 for inflation fluid to the interior of the balloon 44. The distal sleeve 53 of the balloon 44 is sealed to prevent inflation fluid from passing substantially beyond the off axis inflatable portion of the balloon. In this embodiment, inflation fluid delivered through the lumen 37 is directed to the main and off-axis balloons so that the balloons are inflated substantially simultaneously. In other embodiments, the off-axis and main balloons are arranged sequentially along the catheter axis. In other embodiments, the off-axis and main balloons can be provided on separate catheters that are delivered simultaneously or sequentially. In other embodiments, a single balloon is provided that has main and off-axis inflatable regions. Exemplary stent and catheter arrangements are described in US Patent Application Publication No. 2005/0102023, and in U.S. Pat. Nos. 6,325,826; 6,210,429; 6,706,062; 6,596,020; and 6,962,602, all of which are incorporated herein by reference.


Referring to FIGS. 3A and 3B, a polymer tubular parison 55 that has a variable wall thickness is used to effect a desired wall thickness in the balloon 44. Briefly, the parison 55 is oriented inside a mold that has the desired off-axis shape of the balloon. The parison 55 is then heated and pressurized from its interior to expand (arrows 57) the tubular parison 55 by radially stretching the polymer into the shape of the balloon 44. Referring particularly to FIG. 3A, the parison is formed such that its wall thickness varies with the amount of expansion that the parison will undergo during balloon formation. Referring as well to FIG. 3B, the resulting balloon has a wall thickness that is substantially uniform and predictable, thus reducing the likelihood of a thin region that could burst unpredictably. By contrast, a parison with a uniform wall thickness can result in a balloon with greater wall thickness at the base and lesser wall thickness at the dome. For example, the parison 55 has a region 59 that will undergo maximum expansion with a thickness Tpm that is greater than a thickness in Tpi in region 61 that undergoes intermediate expansion. The thickness of the region 61 is in turn greater than the base region 63 which has the least thickness Tpl and undergoes the least expansion. In embodiments, the thicknesses of the balloon wall corresponding to the parison, Tbm, Tbi, and Tbl are substantially the same. In other embodiments, the thickness Tbm of the region of the balloon formed by maximum expansion is about 90% to 110%, e.g. 99 or 95% or more, than the region Tbl formed by minimum expansion. In embodiments, the balloon wall thickness uniformity is ±5%, ±3% or ±1% or less. In other embodiments, variable balloon wall thicknesses can be provided, and/or defined zones having thinner wall thickness are provided to effect a desired balloon burst or folding profile, as will be described below.


Referring to FIGS. 4A-7, balloon manufacture is illustrated in greater detail. Referring particularly to FIGS. 4A, 4B, and 4C, a balloon parison is formed from a length of tubing 72 that is selectively reduced in diameter. The tubing 72 can be formed by extrusion and have a substantially constant wall thickness. The ends of the tubing are reduced by drawing through a temperature-controlled die 74 to form a first reduced end 73 and a second reduced end 75.


Referring as well to FIGS. 5A and 5B, the resulting parison 76 has reduced diameter proximal and distal ends 73, 75 with a nugget 78 between the ends which will be expanded to form the off-axis inflatable portion of the balloon. Referring particularly to FIG. 5B, the wall thickness of the nugget is substantially constant about the parison axis.


Referring to FIGS. 6A to 6C, the parison is treated by laser irradiation to sculpt its wall thickness. Referring particularly to FIG. 6A, the laser radiation 77 is directed on to the nugget 78 to remove polymer material by ablation. A suitable laser is a UV excimer laser operating at, e.g., 193 or 240 nm. The amount of material removed can be controlled by selection of the exposure time and/or laser fluence. Laser ablation is discussed further in U.S. Pat. No. 4,911,711.


Referring particularly to FIGS. 6B and 6C, the resulting processed parison has a wall thickness profile as described above with respect to FIG. 3A, with region 59 having a greater wall thickness than region 61 and region 61 having a greater wall thickness than region 63. The inner diameter of the nugget is not modified by the ablation treatment.


Referring to FIG. 7, the sculpted parison is then placed into a mold 80 formed of first and second halves 81, 82 which are assembled together. The mold halves 81, 82 define a chamber 83 in the desired shape of the inflatable off-axis portion of the balloon. The parison is positioned in the mold such that the nugget 78 is inside the chamber 83 and oriented such that the thicker wall regions are aligned with the region of the mold that will allow greater expansion. The mold is then heated as gas pressure is introduced to the parison so that the nugget expands into the shape of the chamber 83. The parison is then removed from the mold. The unexpanded ends of the balloon form the balloon waists. One end of the parison is sealed by collapsing it upon itself and heating to form melt seal. The other end is left open to provide a path for inflation fluid. The balloon is then attached to the catheter by melt or adhesive bonding. The proximal waist can be bonded to the proximal waist of an off-axis balloon using a mandrel to maintain the inflation fluid flowpath. The substantially unexpanded proximal waist of the off-axis balloon maintains sufficient stiffness to prevent collapse during inflation of the on-axis balloon.


Referring to FIGS. 8-11, the thickness of the parison can be varied to produce other desired balloon profiles. Referring to FIG. 8, a parison 90 has a wall thickness that varies such that the inner 91 and outer 92 wall surfaces of the parison are both circular but at offset centers. The parison can be positioned in a mold with a circular cross-sectional profile. Referring to FIG. 9, a parison 100 has the inner wall 101 that is circular and outer wall 102 that is oval. The parison can be expanded in an elliptical mold to form an elongated oval balloon. Referring to FIG. 10, a parison 110 has an elliptical outer wall surface 111 and a circular inner wall surface 112. The parison is placed inside of an elliptical mold to form an elliptically shaped balloon. Referring to FIG. 11, the parison has inner 121 and outer 122 wall surfaces defining offset ellipses. The parison can be expanded in an elliptical mold to form an elliptical balloon. By selecting a desired inner and outer geometry, the material distribution in the resulting balloon can be controlled.


In other embodiments, the shape of the mold can match the shape of the inner surface of the parison or have a curvature between the inner and outer wall surfaces to provide fine variations in shape and wall thickness in the balloon. For example, it may be desirable to have a slightly thicker wall surface on the sides of the off-axis balloon than on the apex, since the sides of the balloon have greater engagement with the stent during expansion. In other embodiments, the parison can be shaped by techniques other than ablation. For example, the parison can be ground or shaved with a blade or the parison can be extruded to have a variable wall thickness. The balloon sleeve or waist regions of an extruded parison of variable wall thickness can be ground or laser ablated to provide a substantially constant wall thickness in these regions.


Referring to FIG. 12, in some embodiments, a balloon formed from a parison with a profile shown in FIG. 8 results in a balloon having the following dimensions. At its bottom, the balloon has a thickness Tbot of about 27 microns. At its side, the balloon has a thickness Tside of about 15 microns. At its top, the balloon has a thickness T90° of about 11.2 microns. At its top, about 30° away from the center of the top, the balloon has a thickness T60° and T120° of about 11 and 11.3 microns, respectively. The parison had a Tbot of about 100-130 microns before ablation and a thickness of 25-50 microns in ablated areas and a Tside a thickness of about 25-100 microns in unablated areas (or prior to ablation) and a thickness of about 12-25 microns after ablation. The dimension of the wall thickness changes as the height of the balloon changes. The parison from which the balloon was formed had thickness dimensions of about 635 microns and about 940 microns.


Referring as well to FIGS. 13A-13C and 14A-14C, an off-axis balloon 130 is modified to provide a selected burst profile, such that balloon burst will occur outside of the stent and side branch to reduce the likelihood the balloon will become entangled with the stent. Referring particularly to FIGS. 13A and 13B, balloon 130 includes a first preferential burst region 131 at its base and second preferential burst regions 132 in the lower region of the off-axis inflated portion. The preferential burst regions 131, 132 will fail before the areas outside the preferential burst regions 131, 132, creating failure regions 131′, 132′. The thickness of the balloon wall in these regions is selected to fail above a given inflation pressure. Referring particularly to FIG. 13C, should the inflation pressure exceed the burst limit, the reduced thickness regions will fail before other regions of the balloon such as the regions directly engaging the stent. Referring to FIGS. 14A to 14C, the burst regions and can be formed by forming zones of reduced thickness 135, 136 in a parison 133 and then expanding the parison to form the balloon 130. The preferential burst regions 135, 136 will fail before the areas outside the preferential burst regions 131,132, creating failure regions 135′, 136′. Alternatively, the zones of reduced thickness can be formed on the balloon after expanding the parison. The zones of reduced thickness can be formed by e.g. laser irradiation. In embodiments, the burst regions cover 5% or less, e.g. 1% or less of the balloon surface. In embodiments, the wall thickness of the burst regions is e.g. about 90% or less, e.g. 50-75% of the maximum wall thickness of the off-axis inflatable portion of the balloon.


Referring to FIGS. 15-18B, a balloon 140 is such that the balloon deflates into a desired small diameter profile to facilitate removal as the catheter is withdrawn from the stent and the body. Referring particularly to FIGS. 15, 16A and 16B, the balloon 140 includes a refolding region 141 at its base 145 that has enhanced flexibility. Referring particularly to FIGS. 17A and 17B, as the inflation fluid is withdrawn from the balloon, the balloon wall folds at the region 141 to form two wing lobes 142, 143. Referring as well to FIGS. 18A and 18B, at full deflation, the balloon folds into two wings 142, 143 that provide a reduced diameter profile that facilitates withdrawal from the deflated balloon from the stent and the catheter from the lumen. As illustrated in FIGS. 16B, 17B, and 18B, the folds 142, 143 form on either side of a catheter shaft 147.


Referring to FIGS. 19A, 19B, 20A, and 20B, balloon deflation is facilitated by multiple preferential fold regions at its base. Referring particularly to FIGS. 19A and 19B, a balloon 150 has two fold regions 151, 152, which facilitate the formation of two wings 153, 154 and folding inwardly of the ends 155, 156 of the wings. Referring particularly to FIGS. 20A and 20B, a balloon 160 has five fold regions 161-165 which facilitate the formation of two lobes 166, 167 and folding inward of the two lobes.


The preferential fold regions can be formed by providing increased flexibility in the regions. The increase flexibility can be provided by reducing the wall thickness of the balloons in the fold regions, e.g. by forming reduced thickness regions in the parison, as described above, or other techniques can be utilized to vary flexibility. For example, balloon stiffness can be varied by varying the crystallinity of the polymer by exposure to heat, electromagnetic radiation, or ion beam treatments. Varying polymer flexibility is discussed in U.S. patent application Ser. No. 11/355,392, filed Feb. 16, 2006, and U.S. patent application Ser. No. 11/060,151, filed Feb. 17, 2005, both of which are incorporated herein by reference in their entirety. In embodiments, the fold regions cover 5% or less, e.g. 1% of the balloon area. For regions of reduced thickness, the regions have a thickness of about 90% or less, e.g. 50-75% of the maximum wall thickness of the off-axis inflatable portion of the balloon. In particular embodiments, the folding regions are elongated regions having a wall thickness of about 5 mm or less, e.g. 0.2 to 2 mm.


Referring to FIGS. 21A and 21B, balloon folding can also be facilitated with the use of Electro Activated Polymers (EAP's). Referring particularly to FIG. 20A, a balloon 170 includes an EAP strip 171 across the top of the off axis balloon. Referring to FIG. 20B, the EAP strip 171 is activated during deflation such that it expands (arrows), causing the balloon to fold into multiple lobes 172, 173.


Referring as well to FIGS. 22-24, the EAP strips can be configured in various patterns for various folding effects.


Referring particularly to FIG. 23, a balloon 180 on EAP 182 is provided with a linear portion 183 and two orthogonal end portions 184, 184′. When activated, the linear portion displaces the balloon along the axis A region and the end portions 184, 184′, which are tapered to correspond to the curvature of the balloon, expand to fold the balloon into two lobes about the linear portion.


Referring particularly to FIG. 23, a balloon 190 includes an EAP 192 in a cross form, with enlarged ends, 193, 193′, 194, 194′. When activated, the EAP expands (arrows) to fold the balloon into two lobes along the axis. The enlarged ends expand to a greater extent, enhancing the folding effect. The amount of change in dimension is proportional to the original dimension. Larger dimensions experience larger changes in dimension similar to the strain formula.


Referring to FIG. 24, a balloon 200 includes multiple EAP strips 203, 203′, 204, 204′. When activated, the strips expand to fold the balloon into two lobes.


EAP's can also be utilized such that they contract when activated. The EAP's can be attached to the balloon by adhesive, melt bonding or by coextrusion. The EAP's can be selectively actuated by wires attached to the EAP's and extending along the catheter where they are attached to a source of electrical current and a controller. The wires can be directed through the catheter body and also can be embedded in the balloon polymer. Suitable EAP's are described in U.S. application Ser. No. 11/506,491, filed Aug. 18, 2006, entitled “Electrically Actuated Annelid”, the entirety of which is incorporated by reference herein.


Referring to FIGS. 25 and 26, a side branch balloon 300 can be ablated, such as by using laser ablation, to reduce the amount of balloon withdrawal force from a deployed stent. Mass can be removed from the base 310 of the balloon 300 and/or from areas 315 that are adjacent to the base 310. In some embodiments, only the side branch portion 320 of the balloon is ablated. In other embodiments, both the side branch portion 320 and adjacent portions 325 of the sleeves 330 are ablated. In some embodiments, the side branch portion 320 is ablated 360° around the balloon, as shown in FIG. 26. In some embodiments, the portion of the side branch portion 320 that is furthest from the base 310 is left un-ablated. The balloon can be ablated, such as by using a UV laser operating at 193 nm using an energy setting of about 100 mJ or about 150 mJ on a balloon formed of PEBAX®. Ablating the base and adjacent portions can reduce the thickness and stiffness of the balloon, which can aid in refolding the side balloon and decreasing balloon withdrawal force.


Referring to FIG. 27, ablating the bottom of the balloon at the transition to the sleeve can produce wall thickness reduction that assists in withdrawal of the balloon from a lumen or stent. An axial cross section shows the wall thickness as being substantially uniform, except in regions of the base 310, where the wall thickness is reduced. The wall thickness is also reduced in the region where the dome transitions into the sleeves, because of having been ablated.


Suitable balloon polymers include biaxially oriented polymers, thermoplastic lastomers, engineering thermoplastic elastomers, polyethylenes, polyethylene terephthalate (PET), polybutylenes, polyamids (e.g. nylon 66), polyether block amides (e.g., PEBAX®), polypropylene (PP), polystyrene (PS), polyvinyl chlorides (PVC), polytetrafluorethylene (PTFE), polymethylmethacrylate (PMMA), polyimide, polycarbonate (PC), polyisoprene rubber (PI), nitrile rubbers, silicone rubbers, ethylene-propylene diene rubbers (EPDM), butyl rubbers (BR), thermoplastic polyurethanes (PU) (e.g., those based on a glycol ether and an isocyanate, such as PELLETHANE®). In particular embodiments, a poly(ether-amide) block copolymer having the general formula




embedded image



in which PA represents a polyamide segment, e.g., nylon 12, and PE represents a polyether segment, e.g., poly(tetramethylene glycol) is utilized. Such polymers are commercially available from ARKEMA under the tradename PEBAX®. The balloon can be formed of single polymer or of multiple polymers, e.g. by coextrusion. The balloon can be a multilayer balloon formed by, e.g. a coextrusion process. Balloon extrusion and blow molding are described further in Sahatjian, U.S. Pat. No. 5,306,246, “Balloon for Medical Catheter”, the entirety of which is incorporated by reference herein. In embodiments, for processing PEBAX® material laser radiation at 193 nm is used. For PET, radiation of 240 nm is used. In embodiments, the balloon wall has a maximum thickness of about 0.008 inch or less, e.g. 0.003-0.007 inch and a burst strength of about 5 atm, e.g., 10 atm or more. The balloons can be used in vascular and nonvascular applications, including coronary, peripheral, carotid, esophageal or uretheral applications.


Referring to FIGS. 28 and 29, other side branch balloons can be treated to form folding regions or bursting regions. A side branch balloon 335 can have offset sleeves 337, that is, when the balloon is viewed from the top or bottom the sleeves 337 do not intersect a center of the bottom 343 of the dome. The offset sleeve side branch balloon 335 can have a burst region 341 in the lower region of the balloon. Alternatively, the burst region can be in the side of the dome, as with balloons with centered sleeves (see FIG. 13C). Alternatively, or in addition, an offset sleeve side branch balloon 350 can have folding regions 353, such as in line with the sleeve. The balloon 350 can also have folding regions 355 parallel to but not along the axis of the sleeves.


Embodiments may include one or more of the following advantages. Balloon treatment of bifurcated lumens can be facilitated by reducing the likelihood that the balloon will burst on inflation, particularly in a side branch. In addition, balloon burst, should it occur, can be made more predictable, and particularly located outside the side branch, so as to minimize engagement or snagging of a stent expanded in the side branch. The profile of the side branch balloon on deflation after angioplasty or stent delivery can be reduced, e.g. by folding or forming into a desired, predictable configuration that facilitates withdrawal from a deployed stent or body lumen. It can require less withdrawal force to remove a balloon that has been ablated from a lumen than to remove a similar balloon that has not been ablated from the same lumen.


All patents, patent applications, and publications referenced herein are incorporated by reference in their entirety.


A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. The invention's scope is, of course, defined in the language in which the appended claims are expressed.

Claims
  • 1. A method of forming a balloon for treating a bifurcated lumen, the method comprising: providing a tubular parison defining an axis and having a variable wall thickness region;utilizing the variable wall thickness region of the tubular parison to form a balloon inflatable off the axis; andexpanding the tubular parison to form the balloon such that a first region of the tubular parison having a greater thickness is expanded to a greater extent than a second region of the tubular parison having a lesser thickness, and in an expanded state the first region has a lesser thickness than the second region.
  • 2. The method of claim 1 further comprising: forming the balloon by expanding the tubular parison in a mold shaped to correspond to a balloon inflatable off of the axis; andorienting the tubular parison in the mold such that the first region of the tubular parison having a greater wall thickness is expanded to a greater extent than the second region of the tubular parison having a lesser thickness.
  • 3. The method of claim 1 further comprising forming a predefined burst region in the balloon, wherein the predefined burst region is a localized zone in which the balloon wall thickness is reduced.
  • 4. The method of claim 1 further comprising forming a predefined folding region in the balloon, wherein the predefined folding region is a zone of increased flexibility.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Application No. 61/059,250 filed on Jun. 5, 2008, the entire contents of which is hereby incorporated by reference. This application is related to U.S. application Ser. No. 11/599,049, filed Nov. 14, 2007, and U.S. application Ser. No. 12/479,632 filed on even date herewith, which claims the benefit of U.S. Provisional Application Ser. No. 61/059,243 filed Jun. 5, 2008, the entire contents of all of which are hereby incorporated by reference.

US Referenced Citations (464)
Number Name Date Kind
1596754 Moschelle Aug 1926 A
3657744 Ersek Apr 1972 A
3872893 Roberts Mar 1975 A
4140126 Choudhury Feb 1979 A
4309994 Grunwald Jan 1982 A
4410476 Redding et al. Oct 1983 A
4413989 Schjeldahl et al. Nov 1983 A
4421810 Rasmussen Dec 1983 A
4453545 Inoue Jun 1984 A
4479497 Fogarty et al. Oct 1984 A
4503569 Dotter Mar 1985 A
4552554 Gould et al. Nov 1985 A
4681570 Dalton Jul 1987 A
4689174 Lupke Aug 1987 A
4731055 Melinyshyn et al. Mar 1988 A
4733665 Palmaz Mar 1988 A
4739662 Foote Apr 1988 A
4759748 Reed Jul 1988 A
4762128 Rosenbluth Aug 1988 A
4769029 Patel Sep 1988 A
4819664 Nazari Apr 1989 A
4872874 Taheri Oct 1989 A
4878495 Grayzel Nov 1989 A
4896670 Crittenden Jan 1990 A
4900314 Quackenbush Feb 1990 A
4906244 Pinchuk et al. Mar 1990 A
4909258 Kuntz et al. Mar 1990 A
4911711 Telfair et al. Mar 1990 A
4941877 Montano, Jr. Jul 1990 A
4946464 Pevsner Aug 1990 A
4957501 Lahille et al. Sep 1990 A
4957508 Kaneko et al. Sep 1990 A
4963313 Noddin et al. Oct 1990 A
4964850 Bouton et al. Oct 1990 A
4983167 Sahota Jan 1991 A
4994071 MacGregor Feb 1991 A
5042976 Ishitsu et al. Aug 1991 A
5054501 Chuttani et al. Oct 1991 A
5059177 Towne et al. Oct 1991 A
5061240 Cherian Oct 1991 A
5064435 Porter Nov 1991 A
5085664 Bozzo Feb 1992 A
5102403 Alt Apr 1992 A
5102417 Palmaz Apr 1992 A
5104404 Wolff Apr 1992 A
5117831 Jang et al. Jun 1992 A
5122125 Deuss Jun 1992 A
5135536 Hillstead Aug 1992 A
5147317 Shank et al. Sep 1992 A
5147385 Beck et al. Sep 1992 A
5156785 Zdrahala Oct 1992 A
5159920 Condon et al. Nov 1992 A
5192297 Hull Mar 1993 A
5195970 Gahara Mar 1993 A
5195984 Schatz Mar 1993 A
5211683 Maginot May 1993 A
5217440 Frassica Jun 1993 A
5222971 Willard et al. Jun 1993 A
5226913 Pinchuk Jul 1993 A
5234457 Andersen Aug 1993 A
5236446 Dumon Aug 1993 A
5257974 Cox Nov 1993 A
5263932 Jang Nov 1993 A
5304220 Maginot Apr 1994 A
5306246 Sahatjian et al. Apr 1994 A
5320605 Sahota Jun 1994 A
5324257 Osborne et al. Jun 1994 A
5334153 McIntyre et al. Aug 1994 A
5337733 Bauerfeind et al. Aug 1994 A
5338300 Cox Aug 1994 A
5342295 Imran Aug 1994 A
5342297 Jang Aug 1994 A
5342387 Summers Aug 1994 A
5350395 Yock Sep 1994 A
5382472 Yanidis et al. Jan 1995 A
5383892 Cardon et al. Jan 1995 A
5387235 Chuter Feb 1995 A
5395332 Resseman et al. Mar 1995 A
5395334 Keith et al. Mar 1995 A
5404887 Prather Apr 1995 A
5409458 Khairkhahan et al. Apr 1995 A
5413581 Goy May 1995 A
5413586 Dibie et al. May 1995 A
5417208 Winkler May 1995 A
5425765 Tiefenbrun et al. Jun 1995 A
5437638 Bowman Aug 1995 A
5443497 Venbrux Aug 1995 A
5445624 Jimenez Aug 1995 A
5449373 Pinchasik et al. Sep 1995 A
5449382 Dayton Sep 1995 A
5456666 Campbell et al. Oct 1995 A
5456694 Marin et al. Oct 1995 A
5456712 Maginot Oct 1995 A
5456714 Owen Oct 1995 A
5458572 Campbell et al. Oct 1995 A
5458605 Klemm Oct 1995 A
5462530 Jang Oct 1995 A
5476471 Shifrin et al. Dec 1995 A
5489271 Andersen Feb 1996 A
5489295 Piplani et al. Feb 1996 A
5496292 Burnham Mar 1996 A
5505702 Arney Apr 1996 A
5507768 Lau et al. Apr 1996 A
5507769 Marin et al. Apr 1996 A
5514154 Lau et al. May 1996 A
5514178 Torchio May 1996 A
5522801 Wang Jun 1996 A
5531788 Dibie et al. Jul 1996 A
5545132 Fagan et al. Aug 1996 A
5549553 Ressemann et al. Aug 1996 A
5549554 Miraki Aug 1996 A
5562620 Klein et al. Oct 1996 A
5562724 Vorwerk et al. Oct 1996 A
5562725 Schmitt et al. Oct 1996 A
5562726 Chuter Oct 1996 A
5569295 Lam Oct 1996 A
5571087 Ressemann et al. Nov 1996 A
5575771 Walinsky Nov 1996 A
5575817 Martin Nov 1996 A
5575818 Pinchuk Nov 1996 A
5591228 Edoga Jan 1997 A
5593442 Klein Jan 1997 A
5607444 Lam Mar 1997 A
5609605 Marshall et al. Mar 1997 A
5609625 Piplani et al. Mar 1997 A
5609627 Goicoechea et al. Mar 1997 A
5609629 Fearnot et al. Mar 1997 A
5613949 Miraki Mar 1997 A
5613980 Chauhan Mar 1997 A
5613981 Boyle et al. Mar 1997 A
5617878 Taheri Apr 1997 A
5626600 Horzewski et al. May 1997 A
5628788 Pinchuk May 1997 A
5632762 Myler May 1997 A
5632763 Glastra May 1997 A
5632772 Alcime et al. May 1997 A
5634902 Johnson et al. Jun 1997 A
5639278 Dereume et al. Jun 1997 A
5643340 Nunokawa Jul 1997 A
5653743 Martin Aug 1997 A
5662614 Edoga Sep 1997 A
5669924 Shaknovich Sep 1997 A
5669932 Fischell et al. Sep 1997 A
5674197 van Muiden et al. Oct 1997 A
5676696 Marcade Oct 1997 A
5676697 McDonald Oct 1997 A
5679400 Tuch Oct 1997 A
5683451 Lenker et al. Nov 1997 A
5690642 Osborne et al. Nov 1997 A
5693084 Chuter Dec 1997 A
5693086 Goicoechea et al. Dec 1997 A
5693088 Lazarus Dec 1997 A
5697971 Fischell et al. Dec 1997 A
5707354 Salmon et al. Jan 1998 A
5709713 Evans et al. Jan 1998 A
5716365 Goicoechea et al. Feb 1998 A
5716617 Khandke et al. Feb 1998 A
5718683 Ressemann et al. Feb 1998 A
5718724 Goicoechea et al. Feb 1998 A
5720735 Dorros Feb 1998 A
5723004 Dereume et al. Mar 1998 A
5724977 Yock et al. Mar 1998 A
5728158 Lau et al. Mar 1998 A
5733303 Israel et al. Mar 1998 A
5735893 Lau et al. Apr 1998 A
5746766 Edoga May 1998 A
5749825 Fischell et al. May 1998 A
5749848 Jang et al. May 1998 A
5755734 Richter et al. May 1998 A
5755735 Richter et al. May 1998 A
5755770 Ravenscroft May 1998 A
5755771 Penn et al. May 1998 A
5755778 Kleshinski May 1998 A
5759172 Weber et al. Jun 1998 A
5762631 Klein Jun 1998 A
5776101 Goy Jul 1998 A
5776161 Globerman Jul 1998 A
5776180 Goicoechea et al. Jul 1998 A
5782906 Marshall et al. Jul 1998 A
5797947 Mollenauer Aug 1998 A
5800450 Lary et al. Sep 1998 A
5800508 Goicoechea et al. Sep 1998 A
5814061 Osborne et al. Sep 1998 A
5817126 Imran Oct 1998 A
5824008 Bolduc et al. Oct 1998 A
5824036 Lauterjung Oct 1998 A
5824040 Cox et al. Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5824044 Quiachon et al. Oct 1998 A
5827320 Richter et al. Oct 1998 A
5833650 Imran Nov 1998 A
5836966 St. Germain Nov 1998 A
5837008 Berg et al. Nov 1998 A
5838856 Lee Nov 1998 A
5843031 Hermann et al. Dec 1998 A
5843160 Rhodes Dec 1998 A
5843164 Frantzen et al. Dec 1998 A
5846204 Solomon Dec 1998 A
5851210 Torossian Dec 1998 A
5851464 Davila et al. Dec 1998 A
5853389 Hijlkema Dec 1998 A
5855600 Alt Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5865178 Yock Feb 1999 A
5868777 Lam Feb 1999 A
5871536 Lazarus Feb 1999 A
5871537 Holman et al. Feb 1999 A
5891533 Pensero et al. Apr 1999 A
5897588 Hull et al. Apr 1999 A
5906640 Penn et al. May 1999 A
5907893 Zadno-Azizi et al. Jun 1999 A
5913895 Burpee et al. Jun 1999 A
5913897 Corso, Jr. et al. Jun 1999 A
5921958 Ressemann et al. Jul 1999 A
5922020 Klein et al. Jul 1999 A
5928248 Acker Jul 1999 A
5938682 Hojeibane et al. Aug 1999 A
5938696 Goicoecchea et al. Aug 1999 A
5948016 Jang Sep 1999 A
5951599 McCrory Sep 1999 A
5961548 Shmulewitz Oct 1999 A
5967986 Cimochowski et al. Oct 1999 A
5972018 Israel et al. Oct 1999 A
6007517 Anderson Dec 1999 A
6013054 Jiun Yan Jan 2000 A
6013091 Ley et al. Jan 2000 A
6017324 Tu et al. Jan 2000 A
6017363 Hojeibane Jan 2000 A
6024763 Lenker et al. Feb 2000 A
6030414 Taheri Feb 2000 A
6033434 Borghi Mar 2000 A
6033435 Penn et al. Mar 2000 A
6036682 Lange et al. Mar 2000 A
6039749 Marin et al. Mar 2000 A
6042597 Kveen et al. Mar 2000 A
6045557 White et al. Apr 2000 A
6048361 Von Oepen Apr 2000 A
6056775 Borghi et al. May 2000 A
6059823 Holman et al. May 2000 A
6059824 Taheri May 2000 A
6066168 Lau et al. May 2000 A
6068655 Seguin et al. May 2000 A
6071285 Lashinski et al. Jun 2000 A
6086611 Duffy et al. Jul 2000 A
6090127 Globerman Jul 2000 A
6090128 Douglas Jul 2000 A
6090133 Richter et al. Jul 2000 A
6096073 Webster et al. Aug 2000 A
6099497 Adams et al. Aug 2000 A
6117117 Mauch Sep 2000 A
6117156 Richter et al. Sep 2000 A
6126685 Lenker et al. Oct 2000 A
6129738 Lashinski et al. Oct 2000 A
6129754 Kanesaka et al. Oct 2000 A
6142973 Carleton et al. Nov 2000 A
6152945 Bachinski et al. Nov 2000 A
6165195 Wilson et al. Dec 2000 A
6165197 Yock Dec 2000 A
6165214 Lazarus Dec 2000 A
6179867 Cox Jan 2001 B1
6183506 Penn et al. Feb 2001 B1
6183509 Dibie Feb 2001 B1
6190403 Fischell et al. Feb 2001 B1
6193746 Strecker Feb 2001 B1
6203569 Wijay Mar 2001 B1
6210380 Mauch Apr 2001 B1
6210429 Vardi et al. Apr 2001 B1
6217527 Selmon et al. Apr 2001 B1
6217608 Penn et al. Apr 2001 B1
6221080 Power Apr 2001 B1
6221090 Wilson Apr 2001 B1
6221098 Wilson et al. Apr 2001 B1
6231563 White et al. May 2001 B1
6231598 Berry et al. May 2001 B1
6231600 Zhong May 2001 B1
6235051 Murphy May 2001 B1
6241762 Shanley Jun 2001 B1
6258073 Mauch Jul 2001 B1
6258099 Mareiro et al. Jul 2001 B1
6258116 Hojeibane Jul 2001 B1
6258121 Yang et al. Jul 2001 B1
6261273 Ruiz Jul 2001 B1
6261305 Marotta et al. Jul 2001 B1
6261319 Kveen et al. Jul 2001 B1
6264682 Wilson et al. Jul 2001 B1
6273911 Cox et al. Aug 2001 B1
6273913 Wright et al. Aug 2001 B1
6287314 Lee et al. Sep 2001 B1
6290673 Shanley Sep 2001 B1
6293967 Shanley Sep 2001 B1
6299634 Bergeron Oct 2001 B1
6302906 Goicoecchea et al. Oct 2001 B1
6309412 Lau et al. Oct 2001 B1
6309414 Rolando et al. Oct 2001 B1
6312459 Huang et al. Nov 2001 B1
6325821 Gaschino et al. Dec 2001 B1
6325826 Vardi et al. Dec 2001 B1
6334870 Ehr et al. Jan 2002 B1
6346089 Dibie Feb 2002 B1
6350278 Lenker et al. Feb 2002 B1
6355060 Lenker et al. Mar 2002 B1
6358266 Bonutti Mar 2002 B1
6361544 Wilson et al. Mar 2002 B1
6361555 Wilson Mar 2002 B1
6371978 Wilson Apr 2002 B1
6383213 Wilson et al. May 2002 B2
6383215 Sass May 2002 B1
6387120 Wilson et al. May 2002 B2
6395018 Castaneda May 2002 B1
6398792 O'Connor Jun 2002 B1
6398804 Spielberg Jun 2002 B1
6428567 Wilson et al. Aug 2002 B2
6428568 Gaudoin et al. Aug 2002 B2
6428570 Globerman Aug 2002 B1
6432133 Lau et al. Aug 2002 B1
6436104 Hojeibane Aug 2002 B2
6436134 Richter et al. Aug 2002 B2
6468302 Cox et al. Oct 2002 B2
6475208 Mauch Nov 2002 B2
6478816 Kveen et al. Nov 2002 B1
6482211 Choi Nov 2002 B1
6485511 Lau et al. Nov 2002 B2
6494905 Zedler et al. Dec 2002 B1
6508836 Wilson et al. Jan 2003 B2
6511504 Lau et al. Jan 2003 B1
6511505 Cox et al. Jan 2003 B2
6520988 Colombo et al. Feb 2003 B1
6527799 Shanley Mar 2003 B2
6540719 Bigus et al. Apr 2003 B2
6540779 Richter et al. Apr 2003 B2
6544224 Steese-Bradley Apr 2003 B1
6572647 Supper et al. Jun 2003 B1
6579309 Loos et al. Jun 2003 B1
6579312 Wilson et al. Jun 2003 B2
6582394 Reiss et al. Jun 2003 B1
6582459 Lau et al. Jun 2003 B1
6596020 Vardi et al. Jul 2003 B2
6596022 Lau et al. Jul 2003 B2
6599315 Wilson Jul 2003 B2
6599316 Vardi et al. Jul 2003 B2
6602284 Cox et al. Aug 2003 B2
6641609 Globerman Nov 2003 B2
6645241 Strecker Nov 2003 B1
6652873 Deaver et al. Nov 2003 B2
6669717 Marotta et al. Dec 2003 B2
6676667 Mareiro et al. Jan 2004 B2
6679911 Burgermeister Jan 2004 B2
6689156 Davidson et al. Feb 2004 B1
6692483 Vardi et al. Feb 2004 B2
6695877 Brucker et al. Feb 2004 B2
6706062 Vardi et al. Mar 2004 B2
6709440 Matin et al. Mar 2004 B2
6736841 Musbach et al. May 2004 B2
6770092 Richter Aug 2004 B2
6780174 Mauch Aug 2004 B2
6802856 Wilson Oct 2004 B2
6827735 Greenberg Dec 2004 B2
6827736 Perouse Dec 2004 B2
6835203 Vardi et al. Dec 2004 B1
6852124 Cox et al. Feb 2005 B2
6855125 Shanley Feb 2005 B2
6890349 McGuckin, Jr. et al. May 2005 B2
6908477 McGuckin, Jr. et al. Jun 2005 B2
6942689 Majercak Sep 2005 B2
6962602 Vardi et al. Nov 2005 B2
6989025 Burgmeier et al. Jan 2006 B2
7004963 Wang et al. Feb 2006 B2
7056323 Mareiro et al. Jun 2006 B2
7105019 Hojeibane Sep 2006 B2
7118593 Davidson et al. Oct 2006 B2
7125419 Sequin et al. Oct 2006 B2
7163553 Limon Jan 2007 B2
7220275 Davidson et al. May 2007 B2
7238197 Sequin et al. Jul 2007 B2
7244853 Schreiber et al. Jul 2007 B2
7252679 Fischell et al. Aug 2007 B2
7344557 Yadin Mar 2008 B2
7387639 Bourang et al. Jun 2008 B2
7585317 Davidson et al. Sep 2009 B2
7867435 Tran et al. Jan 2011 B2
20010012927 Mauch Aug 2001 A1
20010016767 Wilson et al. Aug 2001 A1
20010016768 Wilson et al. Aug 2001 A1
20010023335 Fischell et al. Sep 2001 A1
20010027291 Shanley Oct 2001 A1
20010027331 Thompson Oct 2001 A1
20010027338 Greenberg Oct 2001 A1
20010029396 Wilson et al. Oct 2001 A1
20010037116 Wilson et al. Nov 2001 A1
20010037138 Wilson et al. Nov 2001 A1
20010037140 Gaudoin et al. Nov 2001 A1
20010037146 Lau et al. Nov 2001 A1
20010037147 Lau et al. Nov 2001 A1
20010039395 Mareiro et al. Nov 2001 A1
20010039448 Dibie Nov 2001 A1
20010041927 Solem Nov 2001 A1
20010047201 Cox et al. Nov 2001 A1
20010049552 Richter et al. Dec 2001 A1
20010056297 Hojeibane Dec 2001 A1
20020013618 Marotta et al. Jan 2002 A1
20020013619 Shanley Jan 2002 A1
20020022874 Wilson Feb 2002 A1
20020026232 Marotta et al. Feb 2002 A1
20020032478 Boekstegers et al. Mar 2002 A1
20020035392 Wilson Mar 2002 A1
20020042650 Vardi et al. Apr 2002 A1
20020052648 McGuckin, Jr. et al. May 2002 A1
20020058990 Jang May 2002 A1
20020072790 McGuckin, Jr. et al. Jun 2002 A1
20020107564 Cox et al. Aug 2002 A1
20020111675 Wilson Aug 2002 A1
20020123790 White et al. Sep 2002 A1
20020123797 Majercak Sep 2002 A1
20020123798 Burgermeister Sep 2002 A1
20020151959 Von Oepen Oct 2002 A1
20020156516 Vardi et al. Oct 2002 A1
20020156517 Perouse Oct 2002 A1
20020165604 Shanley Nov 2002 A1
20020173835 Bourang et al. Nov 2002 A1
20020173840 Brucker et al. Nov 2002 A1
20020177892 Globerman Nov 2002 A1
20020183763 Callol et al. Dec 2002 A1
20020193872 Trout, III et al. Dec 2002 A1
20020193873 Brucker et al. Dec 2002 A1
20030004535 Musbach et al. Jan 2003 A1
20030009209 Hojeibane Jan 2003 A1
20030009214 Shanley Jan 2003 A1
20030014102 Hong et al. Jan 2003 A1
20030023301 Cox et al. Jan 2003 A1
20030028211 Crocker et al. Feb 2003 A1
20030050688 Fischell et al. Mar 2003 A1
20030055378 Wang et al. Mar 2003 A1
20030074047 Richter Apr 2003 A1
20030093109 Mauch May 2003 A1
20030114912 Sequin et al. Jun 2003 A1
20030114915 Mareiro et al. Jun 2003 A1
20030125791 Sequin et al. Jul 2003 A1
20030125799 Limon Jul 2003 A1
20030125802 Callol et al. Jul 2003 A1
20030144683 Sirhan et al. Jul 2003 A1
20030163148 Wang et al. Aug 2003 A1
20040015227 Vardi et al. Jan 2004 A1
20040072849 Schreiber et al. Apr 2004 A1
20040117003 Ouriel et al. Jun 2004 A1
20040133223 Weber Jul 2004 A1
20040133268 Davidson et al. Jul 2004 A1
20040138737 Davidson et al. Jul 2004 A1
20040148006 Davidson et al. Jul 2004 A1
20040225318 Eidenschink et al. Nov 2004 A1
20050015046 Weber et al. Jan 2005 A1
20050015108 Williams et al. Jan 2005 A1
20050027344 Eidenschink Feb 2005 A1
20050060027 Khenansho et al. Mar 2005 A1
20050102019 Yadin May 2005 A1
20050102023 Yadin et al. May 2005 A1
20050177130 Konstantino et al. Aug 2005 A1
20060182873 Klisch et al. Aug 2006 A1
20060184092 Atanasoska et al. Aug 2006 A1
20070191923 Weber et al. Aug 2007 A1
20080097302 Chen Apr 2008 A1
20080109060 Yadin May 2008 A1
20080114294 Holman et al. May 2008 A1
20080125706 Sutermeister et al. May 2008 A1
20080243221 Arcand Oct 2008 A1
Foreign Referenced Citations (69)
Number Date Country
2318314 Jul 1999 CA
9014845.2 Jan 1991 DE
29701758 Mar 1997 DE
0551179 Jul 1993 EP
0646365 Apr 1995 EP
0684022 Nov 1995 EP
0804907 Nov 1997 EP
0876805 Nov 1998 EP
0884028 Dec 1998 EP
0891751 Jan 1999 EP
0897698 Feb 1999 EP
0897700 Feb 1999 EP
0904745 Mar 1999 EP
1031328 Aug 2000 EP
1031330 Aug 2000 EP
1157674 Nov 2001 EP
1254644 Nov 2002 EP
2678508 Jan 1993 FR
WO 8806026 Aug 1988 WO
WO 9013332 Nov 1990 WO
WO 9112779 Sep 1991 WO
WO 9219308 Nov 1992 WO
WO 9426180 Nov 1994 WO
WO 9508965 Apr 1995 WO
WO 9521592 Aug 1995 WO
WO 9629955 Oct 1996 WO
WO 9641592 Dec 1996 WO
WO 9709946 Mar 1997 WO
WO 9716217 May 1997 WO
WO 9726936 Jul 1997 WO
WO 9732544 Sep 1997 WO
WO 9733532 Sep 1997 WO
WO 9741803 Nov 1997 WO
WO 9745073 Dec 1997 WO
WO 9817204 Apr 1998 WO
WO 9819628 May 1998 WO
WO 9835634 Aug 1998 WO
WO 9836709 Aug 1998 WO
WO 9837833 Sep 1998 WO
WO 9844871 Oct 1998 WO
WO 9848733 Nov 1998 WO
WO 9852497 Nov 1998 WO
WO 9915103 Apr 1999 WO
WO 9917680 Apr 1999 WO
WO 9924104 May 1999 WO
WO 9934749 Jul 1999 WO
WO 9936002 Jul 1999 WO
WO 9939661 Aug 1999 WO
WO 9958059 Nov 1999 WO
WO 9965419 Dec 1999 WO
WO 0000104 Jan 2000 WO
WO 0012166 Mar 2000 WO
WO 0013613 Mar 2000 WO
WO 0053122 Sep 2000 WO
WO 0074595 Dec 2000 WO
WO 0121095 Mar 2001 WO
WO 0121109 Mar 2001 WO
WO 0121244 Mar 2001 WO
WO 0170299 Sep 2001 WO
WO 02068012 Sep 2002 WO
WO 02076333 Oct 2002 WO
WO 02094336 Nov 2002 WO
WO 03055414 Jul 2003 WO
WO 2004026180 Apr 2004 WO
WO 2005046757 May 2005 WO
WO 2005122958 Dec 2005 WO
WO 2006014631 Feb 2006 WO
WO 2006053106 May 2006 WO
WO 2008024220 Feb 2008 WO
Non-Patent Literature Citations (14)
Entry
U.S. Appl. No. 12/479,632 to Richard Dunn et al., filed Jun. 5, 2009.
Caputo et al., “Stent Jail: A Minimum-Security Prison,” The American Journal of Cardiology, vol. 77, pp. 1226-1230, Jun. 1, 1996.
Carrie et al., “‘T’-Shaped Stent Placement: A Technique for the Treatment of Dissected Bifurcation Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 37, pp. 311-313, 1996.
Chevalier et al., “Placement of Coronary Stents in Bifurcation Lesions by the ‘Culotte’ Technique,” The American Journal of Cardiology, vol. 82, pp. 943-949, Oct. 15, 1998.
Colombo et al., “‘Kissing’ Stents for Bifurcational Coronary Lesion,” Catheterization and Cardiovascular Diagnosis, vol. 30, pp. 327-330, 1993.
Dichek et al., “Seeding of Intravascular Stents with Genetically Engineered Endothelial Cells,” Circulation,vol. 80, No. 5, pp. 1347-1353, Nov. 1989.
Fischman et al., “A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease,” New England Journal of Medicine, vol. 331, No. 8, pp. 496-501, Aug. 25, 1994.
Katoh et al., “New Double Wire Technique to Stent Ostial Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 40, pp. 400-402, 1997.
“Laser”, Wikipedia, the free encyclopedia, http://en.wikipedia.org./wiki/Laser, printed Mar. 21, 2006, 11 pages.
Lewis et al., “Acute Procedural Results in the Treatment of 30 Coronary Artery Bifurcation Lesions with a Double-Wire Atherectomy Technique for Side-Branch Protection,” American Heart Journal, vol. 127, No. 6, pp. 1600-1607, 1994.
Nakamura et al., “Techniques for Palmaz-Schatz Stent Deployment in Lesions with a Large Side Branch,” Catheterization and Cardiovascular Diagnosis, vol. 34, pp. 353-361, 1995.
Satler et al. “Bifurcation Disease: To Treat or Not to Treat,” Catheterization and Cardiovascular Interventions, vol. 50, pp. 411-412, 2000.
Serruys et al., “A Comparison of Balloon Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease,” The New England Journal of Medicine, vol. 331, No. 8, pp. 489-495, Aug. 25, 1994.
Yamashita et al., “Bifurcation Lesions: Two Stents Versus One Stent—Immediate and Follow-up Results,” Journal of the American College of Cardiology, vol. 35, No. 5, pp. 1145-1151, Apr. 2000.
Related Publications (1)
Number Date Country
20100114018 A1 May 2010 US
Provisional Applications (1)
Number Date Country
61059250 Jun 2008 US